Prediction of drug-target interactions based on substructure subsequences and cross-public attention mechanism.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40445972.
- Also identified by DOI 10.1371/journal.pone.0324146 and PMC identifier 12124583.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Drug-target interactions (DTIs) play a critical role in drug discovery and repurposing. Deep learning-based methods for predicting drug-target interactions are more efficient than wet-lab experiments. The extraction of original and substructural features from drugs and proteins plays a key role in enhancing the accuracy of DTI predictions, while the integration of multi-feature information and effective representation of interaction data also impact the precision of DTI forecasts. Consequently, we propose a drug-target interaction prediction model, SSCPA-DTI, based on substructural subsequences and a cross co-attention mechanism. We use drug SMILES sequences and protein sequences as inputs for the model, employing a Multi-feature information mining module (MIMM) to extract original and substructural features of DTIs. Substructural information provides detailed insights into molecular local structures, while original features enhance the model's understanding of the overall molecular architecture. Subsequently, a Cross-public attention module (CPA) is utilized to first integrate the extracted original and substructural features, then to extract interaction information between the protein and drug, addressing issues such as insufficient accuracy and weak interpretability arising from mere concatenation without interactive integration of feature information. We conducted experiments on three public datasets and demonstrated superior performance compared to baseline models.
Medical subject headings
- Drug Discovery
- Proteins